CONMED Corporation (CNMD)

NYQ – Real Time Price. Currency in USD

35.97

+0.74 (2.10%)

At close: May 12, 2026, 4:00 PM EDT

36.45

+0.48 (1.33%)

Pre-market: May 13, 2026, 7:02 AM EDT

30.04.2026

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CNMD tops Q1 estimates despite sales dip, lifts 2026 organic growth outlook as strategic shift sharpens focus on higher-growth segments.

30.04.2026

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

30.04.2026

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

29.04.2026

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

Conmed (CNMD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.95 per share a year ago.

29.04.2026

CONMED Corporation Announces First Quarter 2026 Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9% in constant currency. Net sales growth was impacted by a $15.5 million decrease in sales from the exit of certain GI products. Domestic revenue decreased 5.8% year-over-year. Domestic sales growth was impacted by a $15.2 million decrease in sales from th.

09.04.2026

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.

02.04.2026

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.

Videos

No Data

There is no data to display

Press releases

29.04.2026

CONMED Corporation Announces First Quarter 2026 Financial Results

28.01.2026

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights Sales of $373.2 million increased 7.9% year-over-year as reported and 7.1% in constant currency. Domestic revenue increased 1.4% year-over-year. International revenue increased 17.0% year-over-year as reported and 15.4% in constant currency. Diluted net earnings per share (GAAP) were $0.54, compared to dilute.

08.01.2026

CONMED Corporation Announces Chief Financial Officer Transition

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026. CONMED has initiated a comprehensive search process, supported by a leading executive search firm, to identify its next Chief Financial Officer. “On behalf of our Board and leadership team, I.

05.12.2025

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets—minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft tissue repair. “Today's announcement reflects a positive step in our strategic portfolio review and o.

CONMED Corporation (CNMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CONMED Corporation (CNMD)

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

CONMED Corporation Announces First Quarter 2026 Financial Results

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Videos

No Data

Press releases

CONMED Corporation Announces First Quarter 2026 Financial Results

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation Announces Chief Financial Officer Transition

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

CONMED Corporation Announces First Quarter 2026 Financial Results

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Videos

No Data

Press releases

CONMED Corporation Announces First Quarter 2026 Financial Results

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation Announces Chief Financial Officer Transition

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

Search stocks

CONMED Corporation (CNMD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

CONMED Corporation (CNMD)

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

CONMED Corporation Announces First Quarter 2026 Financial Results

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Videos

No Data

Press releases

CONMED Corporation Announces First Quarter 2026 Financial Results

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation Announces Chief Financial Officer Transition

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines

CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up

CONMED Corporation (CNMD) Q1 2026 Earnings Call Transcript

Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics

Conmed (CNMD) Q1 Earnings and Revenues Beat Estimates

CONMED Corporation Announces First Quarter 2026 Financial Results

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

Videos

No Data

Press releases

CONMED Corporation Announces First Quarter 2026 Financial Results

CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation Announces Chief Financial Officer Transition

CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines